Journal
AMERICAN JOURNAL OF HYPERTENSION
Volume 15, Issue 1, Pages 9S-13SPublisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0895-7061(01)02274-9
Keywords
atherosclerosis; renin-angiotensin system; angiotensin II receptor blockers
Categories
Ask authors/readers for more resources
Long considered independent risk factors for end-stage vascular disease, hypertension and atherosclerosis may be intimately linked through their effects on vascular endothelial dysfunction, which are mediated by the renin-angiotensin system (RAS), Angiotensin II, a potent vasoconstrictor and the principal active peptide of the RAS, can also produce structural changes in the vessel wall associated with atherosclerosis. The role of RAS in the pathogenesis of atherosclerosis is supported by several lines of evidence, including the presence and upregulation of angiotensin-converting enzyme (ACE) and angiotensin H in the walls of atherosclerotic arteries. This article reviews recent research showing that administration of the angio-tensin H type 1-receptor blocking agents (ARB) losartan and olmesartan medoxomil to cynomolgus monkeys with diet-induced hyperlipidemia prevents the progression of atherosclerosis. Since these effects have been achieved without altering blood pressure or plasma cholesterol levels significantly, it is suggested that these novel effects of angiotensin II receptor blocker treatment may extend the therapeutic profile of this class of agents in the prevention of human vascular disease. (C) 2002 American Journal of Hypertension, Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available